Serum Tryptophan Metabolite Levels During Sleep in Patients With and Without Irritable Bowel Syndrome (IBS)

Abstract

Poor sleep and stress are more frequently reported by women with irritable bowel syndrome (IBS) than by healthy control (HC) women. The pathophysiology linking poor sleep and stress to gastrointestinal symptoms remains poorly understood. We used a metabolomic approach to determine whether tryptophan (TRP) metabolites differ between women with and without IBS and whether the levels are associated with sleep indices and serum cortisol levels. This study sample included 38 women with IBS and 21 HCs. The women were studied in a sleep laboratory for three consecutive nights. On the third night of the study, a social stressor was introduced, then blood samples were drawn every 20 min and sleep indices were measured. Metabolites were determined by targeted liquid chromatography tandem mass spectrometry in a sample collected 1 hr after the onset of sleep. The ratios of each metabolite to TRP were used for analyses. Correlations were controlled for age and oral contraceptive use. Melatonin/TRP levels were lower (p = .005) in the IBS-diarrhea group versus the IBS-constipation and HC groups, and kynurenine/TRP ratios tended to be lower (p = .067) in the total IBS and IBS-diarrhea groups compared to HCs. Associations within the HC group included melatonin/TRP with polysomnography-sleep efficiency (r = .61, p = .006) and weaker positive correlations with the other ratios for either sleep efficiency or percentage time in rapid eye movement sleep (r > .40, p = .025–.091). This study suggests that reductions in early nighttime melatonin/TRP levels may be related to altered sleep quality in IBS, particularly those with diarrhea.

Keywords

metabolomics irritable bowel syndrome sleep tryptophan melatonin

Get full access to this article

View all access options for this article.

References

Asp

Holtze

Powell

S. B.

Karlsson

Erhardt

(2010). Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice. International Journal of Neuropsychopharmacology, 13, 475–485. doi:10.1017/s1461145709990253

Badawy

A. A.

(2013). Tryptophan: The key to boosting brain serotonin synthesis in depressive illness. Journal of Psychopharmacology, 27, 878–893. doi:10.1177/0269881113499209

Clarke

Fitzgerald

Cryan

J. F.

Cassidy

E. M.

Quigley

E. M.

Dinan

T. G.

(2009). Tryptophan degradation in irritable bowel syndrome: Evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterology, 9, 6. doi:10.1186/1471-230x-9-6-

DelRosso

L. M.

Chesson

A. L.

Hoque

(2014). Manual characterization of sleep spindle index in patients with narcolepsy and idiopathic hypersomnia. Sleep Disorders, 2014, 1–4. doi:10.1155/2014/271802

Drossman

Corazziari

Delvaux

Spiller

Talley

Thompson

Whitehead

W. E.

(2006). Rome III: The functional gastrointestinal disorders (3rd ed.). McLean, VA: Degnon Associates, Inc.

Fitzgerald

Cassidy Eugene

Clarke

Scully

Barry

Quigley Eamonn

M. M.

… Dinan Timothy

(2008). Tryptophan catabolism in females with irritable bowel syndrome: Relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterology and Motility, 20, 1291–1297. doi:10.1111/j.1365-2982.2008.01195.x

Fukuda

(2014). Etiological classification of depression based on the enzymes of tryptophan metabolism. BMC Psychiatry, 14, 8. doi:10.1186/s12888-014-0372-y

Heitkemper

M. M.

Cain

K. C.

Deechakawan

Poppe

Jun

S. E.

Burr

R. L.

Jarrett

M. E.

(2012). Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome. Neurogastroenterology and Motility, 24, 626–631, e270–e271. doi:10.1111/j.1365-2982.2012.01915.x

Icenhour

Langhorst

Benson

Schlamann

Hampel

Engler

… Elsenbruch

(2015). Neural circuitry of abdominal pain-related fear learning and reinstatement in irritable bowel syndrome. Neurogastroenterology and Motility, 27, 114–127. doi:10.1111/nmo.12489

10.

Jarrett

Heitkemper

Cain

K. C.

Burr

R. L.

Hertig

(2000). Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Digestive Diseases and Sciences, 45, 952–959.

11.

Kennedy

P. J.

Allen

A. P.

O’Neill

Quigley

E. M.

Cryan

J. F.

Dinan

T. G.

Clarke

(2014). Acute tryptophan depletion reduces kynurenine levels: Implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome. Psychopharmacology, 232, 1357–1371. doi:10.1007/s00213-014-3767-z

12.

Lackner

J. M.

Jaccard

Baum

(2013). Multidomain patient-reported outcomes of irritable bowel syndrome: Exploring person-centered perspectives to better understand symptom severity scores. Value in Health, 16, 97–103. doi:10.1016/j.jval.2012.08.2207

13.

O’Mahony

S. M.

Clarke

Borre

Y. E.

Dinan

T. G.

Cryan

J. F.

(2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277C, 32–48. doi:10.1016/j.bbr.2014.07.027

14.

Savitz

Drevets

W. C.

Smith

C. M.

Victor

T. A.

Wurfel

B. E.

Bellgowan

P. S.

… Dantzer

(2015). Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology, 40, 463–471. doi:10.1038/npp.2014.194

15.

Siah

K. T. H.

Wong

R. K. M.

K. Y.

(2014). Melatonin for the treatment of irritable bowel syndrome. World Journal of Gastroenterology, 20, 2492. doi:10.3748/wjg.v20.i10.2492

16.

Zhang

Gong

J. T.

Zhang

H. Q.

Song

Q. H.

G. H.

Cai

… Zhang

H. W.

(2015). Melatonin attenuates noise stress-induced gastrointestinal motility disorder and gastric stress ulcer: Role of gastrointestinal hormones and oxidative stress. Journal of Neurogastroenterology and Motility, 21, 189–199. doi:10.5056/jnm14119

17.

Zhu

Djukovic

Deng

Himmati

Chiorean

E. G.

Raftery

(2014). Colorectal cancer detection using targeted serum metabolic profiling. Journal of Proteome Research, 13, 4120–4130.